Alzheimer’s disease digital resources lacking for Latinos, Hispanics in Los Angeles years after COVID-19, study finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 21-Sep-2025 20:11 ET (22-Sep-2025 00:11 GMT/UTC)
Although Latinos and Hispanics are at elevated risk for Alzheimer’s disease and account for almost half of Los Angeles County’s population, a recent UCLA Health study finds that accessible digital resources for these communities remain in short supply since the COVID-19 pandemic.
Researchers at the Salk Institute, UC San Diego, and Washington University have gathered novel details on undernourished children’s gut microbe populations in the largest study of its kind to-date, identifying dozens of new microbes to form an unprecedented database. They found that gut microbiome diversity and genome stability may be a powerful marker for whether children thrive or suffer. Their findings pave the way for diagnostic and preventative solutions for undernourished children around the globe, while also opening the opportunity for innovations across other public health crises from obesity to malaria to COVID-19.
Anxiety and depression are major global mental health challenges. Current treatments offer relief but remain unsatisfactory. New research reveals how stress, brain circuits, and genes interact, pointing to better diagnosis and personalized therapies. A recent review in the journal Science China-Life Sciences, led by Chinese researchers, highlights advances from neurobiology, genetics, and psychosocial studies to guide more precise and individualized treatments.
The “great unwinding” at the end of March 2023 meant that more than 25 million people — about 30 percent of all Medicaid recipients — were removed from the program. Now, in the first study of its kind, researchers have analyzed how the unwinding affected the payer mix for children’s emergency department visits in Texas. During the unwinding, about 1.2 million children in the state lost health insurance coverage.
Despite vaccines and treatments, SARS-CoV-2—the virus that causes COVID-19—continues to pose a global health threat, driven by new variants and its ability to hijack human cells in ways that still aren’t fully understood. Now, scientists at Scripps Research have pinpointed dozens of human proteins that SARS-CoV-2 needs to complete its full life cycle, from entering a cell to replicating and releasing new viral particles.
People hesitant about getting a COVID vaccine were more likely to consider getting the shot after hearing a myth explained and corrected with facts, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Science has continually proven the safety and efficacy of COVID vaccines, including the mRNA technology behind their development. However, vaccine hesitancy remains common.
A research team at Saarland University has demonstrated in a clinical study that a widely used anti-allergy nasal spray containing the active ingredient azelastine can significantly reduce the risk of infection with the SARS-CoV-2 virus. The results of the placebo-controlled trial involving 450 healthy participants have now been published in the leading U.S. medical journal JAMA Internal Medicine.